V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20219537 | 20083654 | 1.82 | 83.7 | Palliative (P) | 2020-06-09 | 2020-06-29 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100087099 |
| 20219539 | 20083655 | 1.72 | 73 | Neo-adjuvant (N) | 2018-12-24 | 2018-12-24 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100554231 |
| 20219541 | 20083656 | 1.58 | 102 | Palliative (P) | 2018-07-09 | 2018-07-13 | LENVATINIB | 02 | N | LENVATINIB | 100173387 |
| 20219542 | 20083657 | null | null | null | null | 2018-05-06 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101568979 |
| 20219543 | 20083658 | 1.8 | 100 | null | 2018-12-11 | 2018-12-12 | CISPLATIN + ETOPOSIDE | N | null | CISPLATIN + ETOPOSIDE | 101551737 |
| 20219544 | 20083659 | 1.63 | 102 | Neo-adjuvant (N) | null | 2018-05-30 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101311533 |
| 20219545 | 20083660 | 1.62 | 81 | Palliative (P) | 2018-02-06 | 2018-02-06 | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101073344 |
| 20219546 | 20083661 | null | 57 | Adjuvant (A) | 2017-09-10 | 2017-09-27 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101021874 |
| 20219548 | 20083662 | 1.79 | 102 | Adjuvant (A) | 2021-03-10 | 2021-03-13 | null | null | Y | CETUXIMAB + IRINOTECAN + MDG | 101132069 |
| 20219551 | 20083663 | 1.68 | 91.4 | Palliative (P) | 2017-01-01 | 2017-01-04 | Cape+Cisplatin+Trastuzumab Load | N | N | HCX | 100741801 |
| 20219552 | 20083664 | 1.72 | 57.85 | Palliative (P) | 2016-12-20 | 2016-12-26 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100406534 |
| 20219555 | 20083665 | 1.57 | 69.5 | Palliative (P) | 2017-08-25 | 2017-08-25 | LENVATINIB | 02 | N | LENVATINIB | 101568895 |
| 20219558 | 20083666 | null | null | null | 2018-12-12 | 2018-12-15 | CAPECITABINE + CISPLATIN + Trastuzumab | N | null | HCX | 100491626 |
| 20219564 | 20083669 | 1.85 | 89.6 | Palliative (P) | 2018-12-21 | 2018-12-25 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100607290 |
| 20219566 | 20083670 | 1.6 | 67 | Palliative (P) | 2020-12-14 | 2020-12-27 | CAPECITABINE + CISPLATIN + Trastuzumab | N | N | HCX | 100840072 |
| 20219573 | 20083673 | null | null | null | null | 2018-03-14 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100880522 |
| 20219581 | 20083674 | 1.76 | 70.6 | Palliative (P) | 2018-07-09 | 2018-07-09 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101833456 |
| 20219582 | 20083675 | 1.65 | 89.5 | Palliative (P) | 2020-03-17 | 2020-04-01 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101171036 |
| 20219589 | 20083678 | 1.7 | null | 03 | 2018-09-14 | 2018-09-21 | CAPECITABINE + MITOMYCIN + RT | 02 | N | CAPECITABINE + IRINOTECAN | 100949191 |
| 20219594 | 20083679 | 1.68 | 64 | null | 2020-03-25 | 2020-04-01 | CAPECITABINE + CISPLATIN + Trastuzumab | 2 | null | HCX | 101002397 |
| 20219595 | 20083680 | null | null | null | 2019-03-09 | 2019-03-22 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 101863685 |
| 20219600 | 20083682 | 1.67 | 65.5 | Palliative (P) | 2016-12-15 | 2016-12-18 | null | null | N | LENVATINIB | 100865750 |
| 20219601 | 20083683 | 1.68 | 94.8 | Curative (C) | 2017-08-22 | 2017-09-07 | HCX | N | Y | HCX | 100024552 |
| 20219604 | 20083685 | 1.7 | 68.5 | Neo-adjuvant (N) | null | 2017-02-12 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100175002 |
| 20219606 | 20083686 | 1.73 | null | Palliative (P) | null | 2019-05-26 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 101478741 |
| 20219609 | 20083687 | 1.69 | 84 | 03 | 2019-12-03 | 2019-12-19 | LENVATINIB | 02 | N | LENVATINIB | 100681004 |
| 20219621 | 20083688 | 1.74 | 87.6 | null | 2018-03-19 | 2018-03-19 | LENVATINIB | 02 | Y | LENVATINIB | 101526608 |
| 20219623 | 20083689 | null | null | null | null | 2016-03-26 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101360276 |
| 20219629 | 20083691 | null | null | null | 2017-09-11 | 2017-09-11 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100871747 |
| 20219630 | 20083692 | null | null | null | 2018-02-02 | 2018-02-02 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101420999 |
| 20219636 | 20083693 | 1.6 | 61.9 | Neo-adjuvant (N) | null | 2019-10-13 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100380310 |
| 20219638 | 20083694 | 1.74 | 76.5 | Palliative (P) | 2018-06-23 | 2018-07-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100541592 |
| 20219644 | 20083696 | null | null | null | 2018-05-05 | 2018-05-19 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101727254 |
| 20219645 | 20083697 | 1.76 | 64.8 | 03 | 2018-11-20 | 2018-11-20 | ECarboX | 02 | N | CAPECITABINE + IRINOTECAN | 100984056 |
| 20219647 | 20083699 | null | null | null | 2019-12-30 | 2020-01-12 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101771840 |
| 20219658 | 20083700 | null | null | null | 2019-02-04 | 2019-02-04 | LENVATINIB | 99 | null | LENVATINIB | 101010931 |
| 20219660 | 20083701 | 1.69 | null | Palliative (P) | null | 2016-04-11 | null | null | N | LENVATINIB | 100670712 |
| 20219666 | 20083702 | 1.7 | 56.3 | null | 2015-07-09 | 2015-07-10 | Enzalutamide | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100279843 |
| 20219669 | 20083703 | 1.61 | 111 | Palliative (P) | 2019-01-15 | 2019-01-28 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100138824 |
| 20219670 | 20083704 | 1.75 | 74.4 | null | 2019-07-12 | 2019-08-06 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100888433 |
| 20219673 | 20083705 | null | 0 | Neo-adjuvant (N) | 2017-03-19 | 2017-03-26 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101842481 |
| 20219677 | 20083706 | 1.78 | 83 | Palliative (P) | 2018-06-24 | 2018-07-06 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101692679 |
| 20219678 | 20083707 | 1.6 | 60.4 | Curative (C) | 2019-02-18 | 2019-03-05 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 100362065 |
| 20219680 | 20083708 | 1.56 | 79.3 | Palliative (P) | 2018-05-08 | 2018-05-09 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101156845 |
| 20219682 | 20083709 | 0 | 0 | Neo-adjuvant (N) | 2017-03-16 | 2017-03-16 | Enzalutamide | 02 | Y | CISPLATIN | 100591294 |
| 20219687 | 20083710 | null | 0 | Palliative (P) | 2017-04-01 | 2017-04-01 | Enzalutamide | 02 | N | CETUXIMAB | 100448330 |
| 20219688 | 20083711 | 1.75 | 104 | null | 2019-11-19 | 2019-11-21 | Enzalutamide | 2 | N | CETUXIMAB | 100678756 |
| 20219689 | 20083712 | 1.62 | 73.5 | Neo-adjuvant (N) | 2014-04-08 | 2014-04-22 | Enzalutamide | 02 | Y | CAPECITABINE + TEMOZOLOMIDE | 100167033 |
| 20219690 | 20083713 | 0 | 0 | Palliative (P) | 2018-08-11 | 2018-08-25 | Enzalutamide | 02 | Y | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100577395 |
| 20219696 | 20083714 | 1.7 | 77.7 | Palliative (P) | 2018-03-07 | 2018-03-07 | Enzalutamide | 02 | N | ECF | 101546010 |